Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2026-01-04 @ 9:35 AM
Study NCT ID:
NCT00980395
Status:
COMPLETED
Last Update Posted:
2019-12-30
First Post:
2009-09-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma
Sponsor:
University of Arizona
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2014-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-14
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-18
First Submit QC Date:
None
Study First Post Date:
2009-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-24
Results First Submit QC Date:
None
Results First Post Date:
2019-10-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-16
Last Update Post Date:
2019-12-30
Last Update Post Date Type:
ACTUAL